Companies / Sight Sciences, Inc. / Activity
Activity — Sight Sciences, Inc.
26 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jan 2, 2026 | Badawi Paul CEO | Sell | Common Stock | $188.4K | -25K -0.43% | 5,937,146 10.78% of shares | medium |
| Jan 16, 2026 | Badawi Paul CEO | Sell | Common Stock | $148.0K | -22K -0.37% | 6,025,840 10.94% of shares | medium |
| Jan 6, 2026 | Badawi Paul CEO | Sell | Common Stock | $88.8K | -12K -0.20% | 5,925,276 10.76% of shares | low |
| Jan 5, 2026 | Bauerlein Alison Executive | Sell | Common Stock | $85.2K | -11K -1.76% | 609,630 1.11% of shares | low |
| Jan 5, 2026 | Hayden Jeremy B. Executive | Sell | Common Stock | $73.4K | -9K -3.66% | 247,205 0.45% of shares | low |
| Jan 6, 2026 | Bauerlein Alison Executive | Sell | Common Stock | $72.2K | -10K -1.58% | 599,983 1.09% of shares | low |
| Jan 16, 2026 | Hayden Jeremy B. Executive | Sell | Common Stock | $41.8K | -6K -2.30% | 267,611 0.49% of shares | low |
| Jan 5, 2026 | Rodberg James Executive | Sell | Common Stock | $34.4K | -4K -2.77% | 154,440 0.28% of shares | low |
| Jan 16, 2026 | Badawi David Executive | Sell | Common Stock | $32.0K | -5K -0.25% | 1,912,273 3.47% of shares | low |
| Jan 6, 2026 | Badawi David Executive | Sell | Common Stock | $27.6K | -4K -0.19% | 1,917,109 3.48% of shares | low |
| Jan 5, 2026 | Badawi David Executive | Sell | Common Stock | $23.9K | -3K -0.16% | 1,920,804 3.49% of shares | low |
| Jan 2, 2026 | Badawi David Executive | Sell | Common Stock | $21.7K | -3K -0.15% | 1,923,855 3.49% of shares | low |
| Jan 16, 2026 | Rodberg James Executive | Sell | Common Stock | $17.3K | -3K -1.70% | 151,230 0.27% of shares | low |
| Jan 6, 2026 | Hayden Jeremy B. Executive | Sell | Common Stock | $13.4K | -2K -0.72% | 245,420 0.45% of shares | low |
| Feb 19, 2026 | Badawi David Executive | Exercise | Common Stock | $4.9K | +21K +1.08% | 1,998,458 3.63% of shares | low |
| Jan 6, 2026 | Taylor Brenton Executive | Sell | Common Stock | $4.6K | -619 -0.36% | 170,212 0.31% of shares | low |
| Jan 6, 2026 | Rodberg James Executive | Sell | Common Stock | $4.4K | -594 -0.38% | 153,846 0.28% of shares | low |
| Jun 4, 2026 | Zurbay Donald Director | Grant | Common Stock | $0 | +28K +17.09% | 193,613 0.35% of shares | low |
| Jun 4, 2026 | Burbach Gerhard F Director | Grant | Common Stock | $0 | +28K +29.77% | 123,207 0.22% of shares | low |
| Feb 3, 2026 | Hayden Jeremy B. Executive | Grant | Common Stock | $0 | +116K +43.32% | 383,531 0.70% of shares | low |
| Feb 3, 2026 | Taylor Brenton Executive | Grant | Common Stock | $0 | +100K +59.02% | 270,676 0.49% of shares | low |
| Feb 3, 2026 | Bauerlein Alison Executive | Grant | Common Stock | $0 | +128K +21.25% | 727,495 1.32% of shares | low |
| Feb 3, 2026 | Badawi David Executive | Grant | Common Stock | $0 | +65K +3.39% | 1,977,188 3.59% of shares | low |
| Feb 3, 2026 | Badawi Paul CEO | Grant | Common Stock | $0 | +155K +2.56% | 6,180,400 11.22% of shares | low |
| Feb 3, 2026 | Rodberg James Executive | Grant | Common Stock | $0 | +87K +57.49% | 238,170 0.43% of shares | low |
| Feb 19, 2026 | Badawi David Executive | Exercise | Stock Option (Right to Buy) | — | -21K -100.00% | 0 0.00% of shares | low |